These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 26876381)
1. Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma. Kim KT; Kim BS; Kim JH Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381 [TBL] [Abstract][Full Text] [Related]
2. The Proteomic Landscape of Growth Factor Signaling Networks Associated with Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of FAT1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinoma. Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Ko SG; Eun YG Mol Oncol; 2022 Apr; 16(8):1661-1679. PubMed ID: 34939311 [TBL] [Abstract][Full Text] [Related]
4. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR; Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175 [TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of head and neck squamous cell carcinoma. Feldman R; Gatalica Z; Knezetic J; Reddy S; Nathan CA; Javadi N; Teknos T Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1625-38. PubMed ID: 26614708 [TBL] [Abstract][Full Text] [Related]
6. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients. Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083 [TBL] [Abstract][Full Text] [Related]
7. Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas. Driessen JP; van Bemmel AJ; van Kempen PM; Janssen LM; Terhaard CH; Pameijer FA; Willems SM; Stegeman I; Grolman W; Philippens ME Head Neck; 2016 Apr; 38 Suppl 1():E613-8. PubMed ID: 25783872 [TBL] [Abstract][Full Text] [Related]
8. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes. Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688 [TBL] [Abstract][Full Text] [Related]
9. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival. Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337 [TBL] [Abstract][Full Text] [Related]
10. FAT1 as a tumor mutation burden specific gene affects the immunotherapy effect in head and neck squamous cell cancer. Cao H; Lan T; Kuang S; Wang L; Li J; Li Q; Li Y; Xu Q; Chen Q; Ren S; Lan C; Ouyang N; Liao J; Huang Y; Li J Drug Resist Updat; 2024 Sep; 76():101095. PubMed ID: 38986165 [TBL] [Abstract][Full Text] [Related]
11. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma. Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488 [TBL] [Abstract][Full Text] [Related]
12. Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma. Haque SU; Niu L; Kuhnell D; Hendershot J; Biesiada J; Niu W; Hagan MC; Kelsey KT; Casper KA; Wise-Draper TM; Medvedovic M; Langevin SM Head Neck; 2018 Jul; 40(7):1555-1564. PubMed ID: 29575229 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas. Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750 [TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227 [TBL] [Abstract][Full Text] [Related]
16. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer. Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267 [TBL] [Abstract][Full Text] [Related]
17. Identification of human papillomavirus status specific biomarker in head and neck cancer. Kim KY; Zhang X; Cha IH Head Neck; 2015 Sep; 37(9):1310-8. PubMed ID: 24817691 [TBL] [Abstract][Full Text] [Related]
18. Integrative genomic and functional analysis of human oral squamous cell carcinoma cell lines reveals synergistic effects of FAT1 and CASP8 inactivation. Hayes TF; Benaich N; Goldie SJ; Sipilä K; Ames-Draycott A; Cai W; Yin G; Watt FM Cancer Lett; 2016 Dec; 383(1):106-114. PubMed ID: 27693639 [TBL] [Abstract][Full Text] [Related]
19. Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features. Rettig EM; Chung CH; Bishop JA; Howard JD; Sharma R; Li RJ; Douville C; Karchin R; Izumchenko E; Sidransky D; Koch W; Califano J; Agrawal N; Fakhry C Cancer Prev Res (Phila); 2015 Apr; 8(4):287-95. PubMed ID: 25633867 [TBL] [Abstract][Full Text] [Related]
20. Fine-needle aspiration biopsy of HPV-related squamous cell carcinoma of the head and neck: Current ancillary testing methods for determining HPV status. Bernadt CT; Collins BT Diagn Cytopathol; 2017 Mar; 45(3):221-229. PubMed ID: 28134480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]